Revenue was $1.9M (3701.4%) Gross Profit was $1.1M (2390.3%) Operating Income was -$7.1M (-42.2%) Net Income was -$6.9M (33.4%)
—
Market Cap
—
Revenue
—
Net Income
Longevity Health Holdings Inc focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.
No significant events in the past 90 days.